ANIX

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended July 31, 2005, for CopyTele, Inc. (Note: The request metadata listed "Anixa Biosciences Inc," but the provided filing text is for CopyTele, Inc.). The company operates in two segments: encryption products and services, and flat-panel display technology (Flat CRT). The filing highlights a continued reliance on equity financing and stock-based compensation to fund operations, with revenue derived almost exclusively from encryption products.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Increased by approximately $34,000 (9.5%) year-over-year, driven by a $60,000 increase in encryption services, partially offset by a $26,000 decrease in unit sales.
• Gross Margin: Shifted from a profit of $227,733 in the prior year to a loss of $163,834. This deterioration was primarily caused by a $438,000 provision for excess inventory due to changes in product requirements.
• Operating Expenses: Total operating expenses increased by $383,000. Selling, general, and administrative (SG&A) expenses rose by $390,000, largely due to increased professional fees (including costs related to a prior employee theft investigation) and higher employee compensation. R&D expenses remained relatively flat, decreasing slightly by $7,000.
• Liquidity: Cash and cash equivalents decreased by approximately $421,000. However, the company invested $398,000 in short-term certificates of deposit. Financing activities provided $1.28 million, primarily from the exercise of stock options.

Guidance, Outlook, and Risks

• Going Concern: The auditor's report for the fiscal year ended October 31, 2004, raised substantial doubt about the company's ability to continue as a going concern due to recurring net losses and an accumulated deficit of over $71 million. Management believes current resources will sustain operations until the end of the third quarter of fiscal 2006.
• Future Funding: The company anticipates requiring additional funds after the third quarter of fiscal 2006. It may seek to sell debt or equity securities, which could result in dilution. No arrangements for additional financing are currently in place.
• Accounting Changes: The company will adopt SFAS No. 123(R) regarding stock-based compensation commencing with the quarter ending January 31, 2006. This is expected to have a material effect on financial statements, potentially increasing reported net losses.
• Concentration Risk: Revenue and accounts receivable are highly concentrated. One customer represented 78% of total net revenues and 96% of net accounts receivable for the nine months ended July 31, 2005.
• Product Development: The Flat CRT display segment generated no revenue. The company is in the prototype and testing phase for new TFT-based displays and relies on third-party suppliers (e.g., Volga Svet Ltd.) for mass production capabilities.

Investor Verification Checklist

• Inventory Valuation: Verify the realizability of the $555,020 inventory balance, given the $438,000 write-down taken in the current period and the limited sales history.
• Cash Runway: Confirm the timeline for the next capital raise, as management projects a funding gap by the end of Q3 fiscal 2006.
• Customer Concentration: Assess the risk associated with the single customer accounting for 78% of revenue and 96% of receivables.
• Stock-Based Compensation Impact: Review the pro-forma impact of SFAS 123(R) adoption, which could increase the net loss by approximately $2 million for the nine-month period if applied retrospectively.
• Internal Controls: Note the history of employee fraud (approx. $189,000 misappropriated) and the company's reliance on a small accounting staff.